SCHEMBL5838211

SCHEMBL5838211

Cc1cn(-c2ccc(Cl)c(C(=O)NC(O)C3CCCCCC3)c2)c(=O)n1CC(O)CO

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 8/20 0.38
CNR2 P34972 7/20 0.34
CNR1 P21554 7/20 0.34
SMYD3 Q9H7B4 1/20 0.33
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
FAAH O00519 1/20 0.33
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HSP90AA1 P07900 1/20 0.32
G6PD P11413 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32
CCR6 P51684 1/20 0.32
KMT2A Q03164 1/20 0.32
MCL1 Q07820 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6260746 0.94 P2RX7 (0.34) P2RX7CNR2CNR1SMYD3MAPT
SCHEMBL5838500 0.92 P2RX7 (0.39) P2RX7CNR2CNR1SMYD3MAPT
SCHEMBL5837580 0.92 P2RX7 (0.37) P2RX7CNR2CNR1MAPTTP53
SCHEMBL5838192 0.92 P2RX7 (0.37) P2RX7CNR2CNR1MAPTTP53
SCHEMBL5838989 0.91 P2RX7 (0.47) P2RX7CNR2CNR1MAPTMEN1
SCHEMBL5838903 0.91 P2RX7 (0.37) P2RX7CNR2CNR1SMYD3MAPT
SCHEMBL5838488 0.90 P2RX7 (0.39) P2RX7CNR2CNR1MAPTTP53
SCHEMBL5843079 0.87 P2RX7 (0.39) P2RX7CNR2CNR1SMYD3MAPT
SCHEMBL5837096 0.87 P2RX7 (0.39) P2RX7CNR2CNR1SMYD3MAPT
SCHEMBL5838943 0.87 P2RX7 (0.39) P2RX7CNR2CNR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor DOMBROSKI MARK A 2006-09-28 US disclosed
US-7071223-B1 Benzamide inhibitors of the P2X7 receptor PFIZER, INC. (US) 2006-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885CNR2 117/4885CNR1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.